| Literature DB >> 34782586 |
Wei Liu1, Jie Yu2, Yi-Fan Wang3, Qian-Qian Shan4, Ya-Xian Wang1.
Abstract
There is a lack of systematic research on the expression of internal control genes used for gene expression normalization in real-time reverse transcription polymerase chain reaction in spinal cord injury research. In this study, we used rat models of spinal cord hemisection to analyze the expression stability of 13 commonly applied reference genes: Actb, Ankrd27, CypA, Gapdh, Hprt1, Mrpl10, Pgk1, Rictor, Rn18s, Tbp, Ubc, Ubxn11, and Ywhaz. Our results show that the expression of Ankrd27, Ubc, and Tbp were stable after spinal cord injury, while Actb was the most unstable internal control gene. Ankrd27, Ubc, Tbp, and Actb were consequently used to investigate the effects of internal control genes with differing stabilities on the normalization of target gene expression. Target gene expression levels and changes over time were similar when Ankrd27, Ubc, and Tbp were used as internal controls but different when Actb was used as an internal control. We recommend that Ankrd27, Ubc, and Tbp are used as internal control genes for real-time reverse transcription polymerase chain reaction in spinal cord injury research. This study was approved by the Administration Committee of Experimental Animals, Jiangsu Province, China (approval No. 20180304-008) on March 4, 2018.Entities:
Keywords: NormFinder analysis; geNorm analysis; internal control genes; normalization; reference genes; reverse transcription-quantitative polymerase chain reaction; spinal cord injury; stability of gene expression
Year: 2022 PMID: 34782586 PMCID: PMC8643046 DOI: 10.4103/1673-5374.327350
Source DB: PubMed Journal: Neural Regen Res ISSN: 1673-5374 Impact factor: 5.135
Primer sequences of candidate reference genes
| Symbol | Accession number | Primer sequences (5’–3’) | Amplicon size (bp) | Reference |
|---|---|---|---|---|
|
| NM_031144.2 | Sense: TGT CAC CAA CTG GGA CGA TA | 165 | Bonefeld et al., 2008 |
| Antisense: GGG GTG TTG AAG GTC TCA AA | ||||
|
| NM_001271264.1 | Sense: CCC AGG ATC CGA GAG GTG CTG TC | 95 | Gambarotta et al., 2014 |
| Antisense: CAG AGC CAT ATG GAC TTC AGG GGG | ||||
|
| NM_017101.1 | Sense: CCA AAC ACA AAT GGT TCC CAG T | 135 | Bangaru et al., 2012 |
| Antisense: ATT CCT GGA CCC AAA ACG CT | ||||
|
| NM_017008.4 | Sense: CCA CCA ACT GCT TAG CCC CC | 91 | Gambarotta et al., 2014 |
| Antisense: GCA GTG ATG GCA TGG ACT GTG G | ||||
|
| NM_012583.2 | Sense: CTC ATG GAC TGA TTA TGG ACA GGA C | 123 | Peinnequin et al., 2004 |
| Antisense: GCA GGT CAG CAA AGA ACT TAT AGC C | ||||
|
| NM_001109620.1 | Sense: CTC CTC CCA AGC CCC CCA AG | 97 | Gambarotta et al., 2014 |
| Antisense: CAG ACA GCT ATC ATT CGG TTG TCC C | ||||
|
| NM_053291.3 | Sense: GCA GAT TGT TTG GAA CGG TCC | 113 | Martínez-Beamonte et al., 2011 |
| Antisense: TAG TGA TGC AGC CCC TAG ACG T | ||||
|
| XM_001055633.3 | Sense: TCC GAA TAC GAG GGC GGA A | 142 | * |
| Antisense: AGA TGG CCC AGC TTT CTC ATA | ||||
|
| X01117.1 | Sense: ACT CAA CAC GGG AAA CCT CA | 114 | Bangaru et al., 2012 |
| Antisense: AAT CGC TCC ACC AAC TAA GA | ||||
|
| NM_001004198.1 | Sense: TAA TCC CAA GCG GTT TGC TG | 111 | Martínez-Beamonte et al., 2011 |
| Antisense: TTC TTC ACT CTT GGC TCC TGT G | ||||
|
| NM_017314.1 | Sense: TCG TAC CTT TCT CAC CAC AGT ATC TAG | 82 | Gambarotta et al., 2014 |
| Antisense: GAA AAC TAA GAC ACC TCC CCA TCA | ||||
|
| NM_138853.2 | Sense: GCG AGA CTG GAT GAA GGC CAA G | 120 | Gambarotta et al., 2014 |
| Antisense: CCC TCC ACC ACC AGC TCA CTC | ||||
|
| NM_013011.3 | Sense: TTG AGC AGA AGA CGG AAG GT | 136 | Bonefeld et al., 2008 |
| Antisense: GAA GCA TTG GGG ATC AAG AA |
* Designed by Primer Express® software. Actb: Beta-actin; Ankrd27: Ankyrin repeat domain 27; CypA: cyclophilin A; Gapdh: glyceraldehydes-3-phosphate dehydrogenase; Hprt1: hypoxanthine phosphoribosyltransferase 1; Mrpl10: mitochondrial ribosomal protein L10; Pgk1: phosphoglycerate kinase 1; Rictor: RPTOR independent companion of mTOR, complex 2; Rn18s: 18S ribosomal RNA; Tbp: TATA box binding protein; Ubc: ubiquitin C; Ubxn11: UBX domain protein 11; Ywhaz: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta.
The amplification efficiencies of candidate reference genes
| Symbol | Slope |
| Efficiency (%) |
|---|---|---|---|
|
| –3.192 | 0.9714 | 106 |
|
| –3.174 | 0.9996 | 107 |
|
| –3.543 | 0.9985 | 92 |
|
| –3.177 | 0.9871 | 106 |
|
| –3.341 | 0.986 | 99 |
|
| –3.316 | 0.9971 | 100 |
|
| –3.146 | 0.9915 | 108 |
|
| –3.483 | 0.9961 | 94 |
|
| –3.257 | 0.9655 | 103 |
|
| –3.105 | 0.9585 | 110 |
|
| –3.276 | 0.9948 | 102 |
|
| –3.526 | 0.9867 | 92 |
|
| –3.378 | 0.9999 | 98 |
Actb: Beta-actin; Ankrd27: Ankyrin repeat domain 27; CypA: cyclophilin A; Gapdh: glyceraldehydes-3-phosphate dehydrogenase; Hprt1: hypoxanthine phosphoribosyltransferase 1; Mrpl10: mitochondrial ribosomal protein L10; Pgk1: phosphoglycerate kinase 1; Rictor: RPTOR independent companion of mTOR, complex 2; Rn18s: 18S ribosomal RNA; Tbp: TATA box binding protein; Ubc: ubiquitin C; Ubxn11: UBX domain protein 11; Ywhaz: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta.